🚀Enjoy a 7-Day Free Trial Until Jul 20, 2024!

KA

Kali IncOOTC KALY Stock Report

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is KALY undervalued compared to its fair value?

The fair value of KALY stock is hidden USD. Relative to the market price of 0 USD Kali Inc is hidden.

Kali, Inc. engages in the development of pharmaceuticals to treat illnesses, diseases, and chronic pain. The company is headquartered in Quanzhou, Fujian and currently employs 171 full-time employees. The company went IP...[More about valuation]

Kali Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0 $B

Price:

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

2.089

FINANCIALS

Kali financial for reporting period

Income Statement

0.027 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.0076 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.0055 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.027 B 100%
0.012 B 43%
0.0076 B 28%
0.0055 B 21%

Balance Sheet

0.091 B
0.075 B

Financial Position Analysis

Assets

0.091 B
Current Assets
0.084 B
Total non-current assets
0.0064 B

Total current liabilities
0.016 B
Total non-current liabilities

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.0029 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Kali fundamental analysis for trailing twelve months (TTM)

Profitability score


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

35 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
53 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
29 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is KALY attractive for investment based on fundamental analysis?

KALY stock rating is hidden. Kali is a hidden by Eyestock methodology.

Get KALY Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

19

Gross Margin:

44

CFO / Debt ratio:

hidden

Current ratio:

5.189

Debt / Equity ratio:

ROE:

35

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

KALY analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for KALY to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Kali Inc competitors

LL

LLY

Eli Lilly and Co

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs ...

Discover

NO

NOVO B.CO

Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged i...

Discover

JN

JNJ

Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in Ne...

Discover

Kali Inc dividends

KALY dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About KALY stock

About the company Kali Inc

Market cap $B

0

Dividend yield

Shares outstanding

1018.24 B

Website

Kali, Inc. engages in the development of pharmaceuticals to treat illnesses, diseases, and chronic pain. The company is headquartered in Quanzhou, Fujian and currently employs 171 full-time employees. The company went IPO on 2007-02-09. The firm research and development of treatments for various illnesses, diseases and chronic pain as a symptom of various diagnoses. The company also concentrates on the development of health and wellness therapies.

KALY profile

  • Ticker

    KALY

  • Country

    China

  • Exchange

    OOTC - OTC

  • Report currency

    USD - US dollar

  • IPO date

    09 February 2007

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    171

  • City

    Quanzhou

  • Address

    No 1749-1751 Xiangjiang Road, Shishi City

  • Cusip

    483380101